The thalidomide tragedy of 1957 marked a pivotal moment in pharmaceutical history when the drug, prescribed to pregnant women for morning sickness, resulted in severe birth defects in thousands of babies. This disaster highlighted the critical need for stringent drug testing and regulation, leading to significant changes in pharmaceutical legislation worldwide. The public outcry and subsequent legal actions prompted governments to implement stricter guidelines for drug approval and monitoring. The thalidomide case remains a cautionary tale about the importance of safety in medical practices and the ethical responsibilities of pharmaceutical companies.

The tragedy shattered trust in medical authority and pharmaceutical safety, influencing the skeptical and paranoid themes of late 20th-century literature, and inspiring works that critique corporate negligence and the vulnerability of the body to technological intervention.